13F Holdings
中文EN

INNV InnovAge Holding Corp.

Services-Health Services · Nasdaq · SEC CIK 1834376 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY15.1%
TTM net income YoY151.8%
TTM EPS YoY150.0%
Revenue 3-yr CAGR13.3%
Net income 3-yr CAGR—

Margins

Gross margin23.6%
Operating margin1.4%
Net margin0.9%
FCF margin7.5%
EBITDA margin3.6%

Returns

ROE3.6%
ROA1.7%
ROIC (approx.)5.4%
Asset turnover1.90x

Leverage & solvency

Liabilities / assets48.6%
Debt / equity0.19x
Current ratio1.16x
Interest coverage—

Cash quality & payout

Operating cash flow / net income9.95x
Accruals ratio-15.0%
Payout ratio—
Capex / revenue1.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30FY20242024-06-30FY20232023-06-30FY20222022-06-30
Income statement
Revenue$989.71M$853.70M$763.86M$688.09M$698.64M
Gross profit$227.76M$153.64M$132.06M$101.29M$135.37M
SG&A expense$166.49M$122.06M$111.34M$115.64M$101.65M
Operating income$2.62M-$29.76M-$23.18M-$49.40M-$4.41M
Interest expense————$2.53M
Pretax income$266,000-$34.03M———
Income tax$949,000$1.32M$1.40M-$7.24M$723,000
Net income-$2.54M-$30.31M-$21.34M-$40.67M-$6.52M
EBITDA$23.76M-$10.25M-$4.23M-$33.98M$9.52M
EPS (basic)-0.02-0.22-0.16-0.30-0.05
EPS (diluted)-0.02-0.22-0.16-0.30-0.05
Weighted avg. shares (diluted)135.70M135.39M135.90M135.59M135.52M
Balance sheet
Cash & equivalents$97.89M$64.14M$56.96M$127.27M$184.45M
Short-term investments$43.44M$41.77M$45.83M$46.21M$0
Receivables$42.39M$36.37M$48.11M$24.34M$35.91M
Current assets$214.31M$176.11M$173.14M$215.23M$240.96M
PP&E, net$166.09M$168.04M$193.02M$192.19M$176.26M
Goodwill$142.05M$142.05M$139.95M$124.22M$124.22M
Intangibles$3.22M$3.88M$4.54M$5.20M$5.86M
Total assets$557.39M$526.85M$547.66M$567.36M$555.60M
Current liabilities$203.89M$164.81M$138.60M$148.45M$105.31M
Short-term debt$2.54M$2.25M$3.79M$3.79M$3.79M
Long-term debt$45.52M$57.46M$61.48M$64.84M$68.21M
Total debt$48.06M$59.71M$65.27M$68.64M$72.00M
Total liabilities$288.62M$263.94M$247.85M$252.56M$201.85M
Shareholders' equity$235.60M$234.97M$269.26M$296.30M$332.36M
Net debt-$49.83M-$4.43M$8.31M-$58.63M-$112.44M
Shares outstanding136.02M135.44M136.12M135.64M135.53M
Cash flow statement
Operating cash flow$64.71M$32.87M-$36.90M$20.24M$27.30M
Capital expenditure$14.31M$6.26M$7.91M$23.35M$38.24M
Free cash flow$50.41M$26.60M-$44.81M-$3.12M-$10.94M
Investing cash flow-$12.34M-$5.55M-$26.37M-$69.52M-$40.24M
Financing cash flow-$18.53M-$19.08M-$7.03M-$7.90M-$6.32M
Depreciation & amortization$21.14M$19.51M$18.95M$15.42M$13.92M
Stock-based compensation$7.05M$7.62M$6.83M$4.61M$3.74M

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.